RIZAFILM Drug Patent Profile

« Back to Dashboard

When do Rizafilm patents expire, and when can generic versions of Rizafilm launch?

Rizafilm is a drug marketed by Gensco and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in RIZAFILM is rizatriptan benzoate. There is one drug master file entry for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Rizafilm

A generic version of RIZAFILM was approved as rizatriptan benzoate by AUROBINDO PHARMA LTD on December 31^st, 2012.

Summary for RIZAFILM

US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Patent Applications:	928
What excipients (inactive ingredients) are in RIZAFILM?	RIZAFILM excipients list
DailyMed Link:	RIZAFILM at DailyMed

Pharmacology for RIZAFILM

Drug Class	Serotonin-1b and Serotonin-1d Receptor Agonist
Mechanism of Action	Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists

US Patents and Regulatory Information for RIZAFILM

RIZAFILM is protected by one US patents.

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Gensco	RIZAFILM	rizatriptan benzoate	FILM;ORAL	205394-002	Feb 26, 2026		DISCN	Yes	No			Y
Gensco	RIZAFILM	rizatriptan benzoate	FILM;ORAL	205394-001	Apr 14, 2023		RX	Yes	Yes			Y	Y

International Patents for RIZAFILM

See the table below for patents covering RIZAFILM around the world.

Country	Patent Number	Title	Estimated Expiration
Australia	2014298130	Instantly wettable oral film dosage form without surfactant or polyalcohol
Brazil	112016002074	forma de dosagem de película oral instantaneamente molhável sem tensoativo ou poli-álcool
Canada	2919442	FORME POSOLOGIQUE ORALE EN FILM INSTANTANEMENT MOUILLABLE SANS TENSIOACTIF NI POLYOL (INSTANTLY WETTABLE ORAL FILM DOSAGE FORM WITHOUT SURFACTANT OR POLYALCOHOL)
Chile	2016000160	Pelicula oral que comprende hidroxipropilcelulosa sola o combinada con polivinilpirrolidona, al menos un copolímero de vinilpirrolidona, dioxido de titanio, en donde la relación del copolímero de vinilpirrolidona con el dioxido de titanio es de 3 es a 1 a 5 es a 1, y rizatriptán, zolmitriptán, alprazolam, diazepam o lorazepam, como principio activo.

Supplementary Protection Certificates for RIZAFILM

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0497512	98C0037	France		PRODUCT NAME: RIZATRIPTAN BENZOATE; REGISTRATION NO/DATE IN FRANCE: NL 23 695 DU 19980817; REGISTRATION NO/DATE AT EEC: 21 815 DU 19980211
0497512	C980019	Netherlands		PRODUCT NAME: RIZATRIPTAN, DESGEWENST IN DE VORM VAN EEN ZOUT, IN HET BIJZOND ER RIZATRIPTAN-BENZOAAT; REGISTRATION NO/DATE: RVG 21815 - RVG 21818 19980211
0497512	SPC/GB98/035	United Kingdom		PRODUCT NAME: RIZATRIPTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, ESPECIALLY RIZATRIPTAN BENZOATE; REGISTERED: NL 21815 19980211; NL 21816 19980211; NL 21817 19980211; NL 21818 19980211; UK 00025/0369 19980624; UK 00025/0370 19980624; UK 00025/0371 19980624; UK 00025/0372 19980624
0497512	9891028-4	Sweden		PRODUCT NAME: RIZATRIPTAN, N.N-DIMETYL-2-(5-(1, 2, 4-TRIAZOL-1-YLMETYL)-1H-INDOL-3-YL)ET)-1H-I, EVENTUELLT I FORM AV ETT FARMACEUTISKT GODTAGBART SALT, SPECIELLT DA RIZATRIPTANBENSOAT